ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 16 filers reported holding ARCA BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $163,000 | -63.5% | 326,147 | +0.4% | 0.00% | -66.7% |
| Q4 2017 | $447,000 | +73.3% | 324,847 | +38.3% | 0.00% | +50.0% |
| Q3 2017 | $258,000 | -41.5% | 234,847 | +30.6% | 0.00% | -33.3% |
| Q2 2017 | $441,000 | +465.4% | 179,847 | +476.4% | 0.00% | +200.0% |
| Q1 2017 | $78,000 | -78.5% | 31,200 | -75.2% | 0.00% | -50.0% |
| Q3 2016 | $363,000 | -18.1% | 125,733 | -17.7% | 0.00% | -33.3% |
| Q2 2016 | $443,000 | -28.2% | 152,733 | -15.0% | 0.00% | -25.0% |
| Q1 2016 | $617,000 | – | 179,757 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aveo Capital Partners, LLC | 93,258 | $47,000 | 0.02% |
| Tekla Capital Management LLC | 811,227 | $405,000 | 0.02% |
| Virtu Financial LLC | 68,000 | $34,000 | 0.00% |
| ROYCE & ASSOCIATES LP | 326,147 | $163,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 776 | $0 | 0.00% |
| NORTHERN TRUST CORP | 14,074 | $7,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11,124 | $6,000 | 0.00% |
| DEUTSCHE BANK AG\ | 352,030 | $175,000 | 0.00% |
| CREDIT SUISSE AG/ | 20,000 | $10,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 88,994 | $44,000 | 0.00% |